Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
Public ClinicalTrials.gov record NCT03259789. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Bexagliflozin in Subjects With Type 2 Diabetes Mellitus Who Are Not Adequately Controlled by Metformin Alone
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to investigate the effect of bexagliflozin compared to placebo as an add-on therapy to metformin in lowering hemoglobin A1c (HbA1c) levels in subjects with type 2 diabetes mellitus (T2DM).
Study identification
- NCT ID
- NCT03259789
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 351 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 20 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 28, 2017 (Actual)
- Primary completion
- Jan 23, 2019 (Actual)
- Completion
- Jan 23, 2019 (Actual)
- Last update posted
- Jul 7, 2021
2017 – 2019
United States locations
- U.S. sites
- 26
- U.S. states
- 15
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Site 1232 | Birmingham | Alabama | 35205 | — |
| Clinical Research Site 1378 | Birmingham | Alabama | 35242 | — |
| Clinical Research Site 1269 | Foley | Alabama | 36535 | — |
| Clinical Research Site 1363 | Little Rock | Arkansas | 72209 | — |
| Clinical Research Site 1381 | Anaheim | California | 92805 | — |
| Clinical Research Site 1375 | North Hollywood | California | 91606 | — |
| Clinical Research Site 1365 | Norwalk | California | 90650 | — |
| Clinical Research Site 1382 | Norwalk | Connecticut | 06851 | — |
| Clinical Research Site 1372 | Hollywood | Florida | 33024 | — |
| Clinical Research Site 1362 | Palm Springs | Florida | 33461 | — |
| Clinical Research Site 1373 | Pembroke Pines | Florida | 33026 | — |
| Clinical Research Site 1376 | Nampa | Idaho | 83686 | — |
| Clinical Research Site 1366 | Chicago | Illinois | 60602 | — |
| Clinical Research Site 1294 | New Orleans | Louisiana | 70124 | — |
| Clinical Research Site 1374 | St Louis | Missouri | 63117 | — |
| Clinical Research Site 1370 | Las Vegas | Nevada | 89104 | — |
| Clinical Research Site 1009 | Berlin | New Jersey | 08009 | — |
| Clinical Research Site 1037 | Trenton | New Jersey | 08611 | — |
| Clinical Research Site 1286 | Albuquerque | New Mexico | 87102 | — |
| Clinical Research Site 1368 | New York | New York | 10036 | — |
| Clinical Research Site 1275 | The Bronx | New York | 10455 | — |
| Clinical Research Site 1019 | Portland | Oregon | 97239 | — |
| Clinical Research Site 1379 | Gonzales | Texas | 78629 | — |
| Clinical Research Site 1369 | Houston | Texas | 77051 | — |
| Clinical Research Site 1371 | San Antonio | Texas | 78209 | — |
| Clinical Research Site 1360 | San Antonio | Texas | 78258 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03259789, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 7, 2021 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03259789 live on ClinicalTrials.gov.